BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...
A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...
Anal cancer is often linked to HPV, with squamous cell carcinoma being the most common type. Diagnosis involves exams, ...
Dave Coulier recently revealed another cancer diagnosis, mere months after recovering from Stage 3 non-Hodgkin’s lymphoma back in April. The 66-year old “Full House” actor shared that he’s been ...
Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing recurrence risk by 68% in the C-POST trial. Administered post-surgery and radiation ...
Crunch helps immune cells recognize and remove harmful cells by connecting them directly to specific targets, guiding the body’s natural clean-up process. A team of scientists at Kyoto University’s ...
Doctors at the National Institutes of Health have discovered a new cause of skin cancer, according to a case report published Wednesday in the New England Journal of Medicine. The culprit is a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback